ORIX Life Passed 4.5 Million Mark in Number of Insurance Policies in force
- Pursuing the development of products and services in line with the diversifying needs of customers to achieve growth -

TOKYO, Japan - May 27, 2020 - ORIX Life Insurance Corporation (“ORIX Life”) announced that as of March 31, 2020, it has passed the 4.5 million^*1 mark in the number of insurance policies in force signed with the company.

The ORIX Life Philosophy is “Turning ideas into things that resonate with the heart.” Based on this philosophy, ORIX Life pursues the development of products and services in line with the diversifying needs of customers. In April 2019, ORIX Life released the U.S. dollar-denominated whole life insurance “Candle,” its first foreign currency-denominated product that allows, in a rational manner, the ensuring of security for a lifetime and the building up assets. ORIX Life further released three types of simplified issue insurance products in October—the term insurance “FINE Support Plus,” whole life insurance “RISE Support Plus,” and medical insurance “CURE Support Plus”—to provide even more enhanced insurance for people who have chronic diseases and have been hospitalized or operated on.^*2
In addition, from October 2019, ORIX Life also commenced its “Inheritance Support Service” to support inheritance and other procedures and “Hospital Admission and Discharge Support Service, etc. (Housekeeping Services)”*3 for supporting daily life when in hospital for customers with ORIX Life insurance.

ORIX Life was able to pass the 4.5 million mark in number of insurance policies in force due to the patronage of many customers for its various products and services. ORIX Life will continue catering to customers’ needs as well as striving to be an insurance company that is trusted by customers.

*1 Number of insurance policies in force with ORIX Life: 4,526,326 (as of March 31, 2020)
*2 For details about each product, please see the following links.
　U.S. dollar-denominated whole life insurance “Candle”:
　https://www.orix.co.jp/grp/en/newsrelease/190312_ORIXG.html
　Term insurance “FINE Support Plus,” whole life insurance “RISE Support Plus,” and medical insurance “CURE Support Plus”:
　https://www.orix.co.jp/grp/en/newsrelease/190816_ORIXG.html
*3 For details about “Inheritance Support Service” and “Hospital Admission and Discharge Support Service, etc. (Housekeeping Services)”, please see this link:
　https://www.orix.co.jp/grp/en/newsrelease/191001_ORIXG.html

Contact Information:
ORIX Corporation
Corporate Planning Department
Tel: +81-3-3435-3121

About ORIX:
ORIX Corporation (TSE: 8591; NYSE: IX) is a financial services group which provides innovative products and services to its customers by constantly pursuing new businesses.
Established in 1964, from its start in the leasing business, ORIX has advanced into neighboring fields and at present has expanded into lending, investment, life insurance, banking, asset management, automobile related, real estate and environment and energy related businesses. Since entering Hong Kong in 1971, ORIX has spread its businesses globally by establishing locations in 37 countries and regions across the world.
Going forward, ORIX intends to utilize its strengths and expertise, which generate new value, to establish an independent ORIX business model that continues to evolve perpetually. In this way, ORIX will engage in business activities that instill vitality in its companies and workforce, and thereby contribute to society. For more details, please visit our website: https://www.orix.co.jp/grp/en/
(As of March 31, 2020)

Caution Concerning Forward Looking Statements:
These documents may contain forward-looking statements about expected future events and financial results that involve risks and uncertainties. Such statements are based on our current expectations and are subject to uncertainties and risks that could cause actual results that differ materially from those described in the forward-looking statements. Factors that could cause such a difference include, but are not limited to, those described under “Risk Factors” in the Company’s annual report on Form 20-F filed with the United States Securities and Exchange Commission and under “(4) Risk Factors” of the “1. Summary of Consolidated Financial Results” of the “Consolidated Financial Results April 1, 2019 – March 31, 2020.”